Skip to main content
. 2021 Sep 6;12:734638. doi: 10.3389/fendo.2021.734638

Table 3.

Oocyte and embryological data after IVF-ET treatment between insulin resistant (IR) and non-insulin resistant (Non-IR) infertile women.

Non-IR (n = 97) IR (n = 58) P-value
Duration of induction (days) 12.70 ± 3.26 13.83 ± 3.06 0.035a
No. of retrieved oocytes 12.13 ± 7.82 14.28 ± 9.72 0.135
No. of mature oocytes 10.96 ± 7.10 12.19 ± 8.93 0.347
No. of fertilized oocytes 8.93 ± 6.54 9.98 ± 8.15 0.221
% of mature oocytes per oocyte retrieved 90.53 ± 12.91 85.17 ± 15.16 0.02a
% of fertilized oocytes among the mature oocytes 81.46 (866/1063) 81.90 (579/707) 0.820
% of good-quality embryos per cleaved embryos 56.97 (429/753) 56.50 (291/515) 0.869
% of freezable blastocysts per residual embryos 46.46 (269/579) 39.15 (157/401) 0.023a
% of fresh ET cycles in 1st ET cycles 45.98 (40/87) 39.62 (21/53) 0.462
% of chemical pregnancy in 1st ET 28.74 (25/87) 41.51 (22/53) 0.121
% of pregnancy in 1st ET 26.44 (23/87) 32.08 (17/53) 0.474
% of chemical pregnancy loss in 1st ET 8 (2/25) 22.73 (5/22) 0.157
% of clinical pregnancy loss in 1st ET 17.39 (4/23) 35.29 (6/17) 0.196
% of pre-term births in 1st ET 10.53 (2/19) 18.18 (2/11) 0.552
Cumulative live birth rate,% 50.52 (49/97) 46.55 (27/58) 0.633

P < 0.05 was considered statistically significant, aP < 0.05.